The largest database of trusted experimental protocols

9 protocols using apc anti cd8a

1

Multiparametric Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Liver mononuclear cells (MNCs) were purified by a 40%/70% percoll gradient48 (link) and stained with anti-CD3-PE, anti-CD4-PerCP/Cy5.5, anti-CD8a-APC, or anti-CD25-FITC (eBiosciences) for 30 min at 4 °C in staining buffer (PBS, 3% FCS). For detection of intracellular proteins, cells were first stimulated with PMA (Sigma) and inomycin (Sigma) for 4 h and stopped by addition of Brefeldin A (Sigma). After cell surface staining, cells were fixed and permeabilized (eBiosciences), and then stained respectively with anti-IFNγ-FITC, anti-IL-17 A-PE, or anti-Foxp3-PE. For detection of surface expression of IL-17RA in cloned MSCs, cells were stained with anti-IL-17RA-PE (eBiosciences). All samples were analyzed by flow cytometry on a FACS Calibur flow cytometer (Becton Dickinson).
+ Open protocol
+ Expand
2

Tumor-Infiltrating T-Cell Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
At the time of sacrifice, the tumors and spleens were harvested from the mice. Single-cell suspensions of splenocytes were stained with anti-CD3-FITC (cat. no. 11-0032-82; eBioscience, San Diego, USA), anti-CD4-PerCP/Cy5.5 (cat. no. 100540; BioLegend) and anti-CD8a-APC (cat. no. 17-0081-83; eBioscience) at 4 °C for 20 min. The single-cell suspensions of tumors were stained with anti-CD45-R-PE (cat. no. 147711; BioLegend), anti-CD3-FITC, anti-CD8a-APC and anti-IFN-γ-Bv421 (cat. no. 505830; BioLegend) at 4 °C for 20 min. The cells were analyzed by an Attune NxT Flow Cytometer.
+ Open protocol
+ Expand
3

Immune Cell Profiling of Murine Tumors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Orthotopic Met-1 or AT3 tumours were isolated, dissociated into single cell suspension, and incubated for 15 min with anti-mouse CD16/CD32 to reduce non-specific staining. Infiltration of immune cells into tumours was analysed by staining with the following anti-mouse antibodies: CD45-PE/Cy7 (eBioscience, 25-0451-82, diluted 1:200), CD45-BV570 (Biolegend, 103136, diluted 1:100), CD3e-FITC (eBioscience, 14-0031-82, diluted 1:100), CD4-APC/Cy7 (Biolegend, 100414, diluted 1:100), anti-CD8a-APC (eBioscience, 17-0081-82, diluted 1:100), CD11b-PerCP/Cy5.5 (eBioscience; 45-0112-82, diluted 1:100), F4/80-APC (eBioscience, 17-4801-82, diluted 1:50), Ly-6G/Ly-6C (Gr-1)-APC/Cy7 (Biolegend, 108424, diluted 1:100), Ly-6G-APC (Biolegend, 127614, diluted 1:200), Ly-6C-FITC (Biolegend, 128006, diluted 1:200), Ly-6C-BV605 (Biolegend, 128036, diluted 1:200). DAPI was used to exclude dead cells. Acquisition was performed with Beckman-Coulter Gallios flow cytometer and data analysis was done with FlowJo software (version X.0.7).
+ Open protocol
+ Expand
4

Isolation and Characterization of Immune Cells from Mouse Brain

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mouse brains without the cerebellum were coarsely chopped and incubated in a 0.01% collagenase (Sigma–Aldrich, #C0130) solution in PBS at 37 °C for 40 min under agitation. Samples were passed through a 70 μm filter in a total volume of 20 mL PBS. Cell suspension was mixed with a Percoll solution (30% Percoll, GE Healthcare #17089101, 3.33% PBS 10x, and 66,6% PBS 1 ×) and centrifuged for 30 min at 1500 × g. After centrifugation, the supernatant was discarded. Cells forming the pellet were washed twice with PBS, resuspended in PBS supplemented with 2% FCS and incubated for 30 min on ice with fluorescence-conjugated antibodies (1:100 dilution; anti-CD45 FITC, Tonbo Biosciences clone 30-F11; anti-CD11b PECy7, eBiosciences clone M1/70; anti-CD4 PE, Invitrogen #12-0042082; anti-CD8a APC, eBiosciences clone 53-6.7). Samples were washed twice with PBS before cytometry. Acquisition was performed on a MoFlo XDP FACS equipment (Beckman Coulter Inc., Brea, CA). Sorted cells were CD45hiCD4+ (T CD4 lymphocytes), CD45hiCD8+ (T CD8 lymphocytes), CD45hiCD11bhi (activated microglia and/or infiltrating macrophages) and CD45intCD11blo (quiescent microglia). Data were analyzed with FlowJo vX software (Tree Star Inc., Ashland, OR).
+ Open protocol
+ Expand
5

T Cell Phenotypic and Functional Analyses

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following reagents and fluorochrome-conjugated monoclonal antibodies were used in this study for T cell phenotypic and functional analyses: PKH26 membrane dye (Sigma), APC- anti-CD4, APC-anti-CD8a, PE-anti-CD4, PE-anti-CD25, FITC or APC-anti-TNFα, PE-anti-ICOS-L FITC-Annexin-V (all from eBioscience), FITC-anti-CXCR4, APC-anti-CXCR7, PE-anti-hCCR4 (all from R&D Systems), and FITC-anti-CD279/PD-1 (Biolegend, San Diego, CA). Intracellular expression of TNFα was detected following fixation and permeabilization (fixation/permeabilization buffer concentrate, Cat. No. 00-5123-43, diluent, Cat. No. 00-5223-56, and permeabilization buffer, Cat. No. 00-8333-56, all from eBioscience). All samples were analyzed with a FACSCalibur flow cytometer, using CellQuest software (BD Biosciences). For analysis of tumor ascites CD14+ cell phenotype, the following monoclonal antibodies were used: FITC-anti-CD14, PE-anti-CD11b (both from R & D Systems), PE-anti-CD11c, PE-anti-B7-H1, PerCP-anti-CD14 (all from BD Biosciences), FITC-anti-CD279/PD-1, FITC-anti-CD83, FITC-anti-CD80, PE-anti-CD86, APC-anti-CD14, and PE-IL-1β (all from eBioscience). Intracellular expression of IL-1β was assayed following overnight incubation of CD14+ cells in the presence of Brefeldin A, followed by fixation and permeabilization as described above.
+ Open protocol
+ Expand
6

Multiparametric Flow Cytometry for Immune Cell Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following anti-mouse antibodies were from eBioscience: FITC-anti-F4/80, APC-anti-CD80, PE-Cy7-anti-CD86, PE-anti-MHC-II, PE-anti-CD11b, FITC-anti-Gr-1, APC-Cy7-anti-CD3, PerCP-Cyanine5.5-anti-CD4, APC-anti-CD8a, PE-anti-IFN-γ, and FITC-anti-IL-17. For intracellular cytokine staining, cells were stimulated with PMA (50 ng/ml, Enzo Life Sciences) and ionomycin (1 nM, Enzo Life Sciences) in the presence of brefeldin A (1 mg/ml, Enzo Life Sciences) for 4–5 h. Surface staining was performed in FACS buffer (0.5% BSA, 2 mM EDTA, 0.02% sodium azide in PBS) in the presence of Fc receptor blocking antibody (BioLegend) for 20 min at 4°C. Cells were fixed in 4% paraformaldehyde (Electron Microscopy Sciences) for 20 min at room temperature followed by permeabilization (0.1% BSA, 0.5% saponin in PBS) or with the BD Cytofix/Cytoperm Fixation and Permeabilization Kit. Cytokine staining was performed in permeabilization buffer for 20 min at 4°C. Data acquisition and analysis were performed using BD LSRFortessa X-20 (BD Bioscience) and FlowJo software (Tree Star, Ashland, OR, USA) respectively.
+ Open protocol
+ Expand
7

Intracellular Cytokine Detection Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
For intracellular cytokine detection, isolated cells were cultured in 20 μg/ml of M. tuberculosis lysate or PMA/ionomycin for 1.5 h before 10 μg/ml Brefeldin A (eBioscience, USA) was added to the culture for 3.5 h more. For surface staining, lymphocytes were harvested, washed and stained for 30 min on ice with mixtures of fluorescently conjugated mAbs or isotype-matched controls. mAbs of mice were as follows: APC-Cy7-anti-CD3, PE-Cy7-anti-CD4, APC-anti-CD8a, PE-anti-CD45.1, Alexa Fluor 700-anti-CD45.2, PE-anti-CD25, PerCP-cy5.5-anti-CD69, PE-anti-CD44, FITC-anti-CD62L, PE-cy7-anti-Gr-1, PE-anti-CD11b, APC-ant-CD86, Alexa Fluor 700-anti-MHC-II and PerCP-cy5.5-anti-CD206 (eBioscience). For intracellular staining, the cells were incubated 20 min in IC Fixation buffer (eBioscience), followed by permeabilization buffer (eBioscience) and 1 h of incubation with appropriate mAbs of mice: PE-anti-IFN-γ, FITC-anti-IL-17, PerCP-cy5.5-anti-IL-4, FITC-anti-IL-2 and FITC-anti-Foxp3. Cell phenotype was analyzed by flow cytometry on a flow cytometer (BD LSR II) (BD Biosciences, USA). Data were acquired as the fraction of labeled cells within a live-cell gate and analyzed using FlowJo software (Tree Star). All gates were set on the basis of isotype-matched control antibodies.
+ Open protocol
+ Expand
8

CD4+ Cell Depletion and IL-17A Neutralization

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD4+ cells were depleted using anti-CD4 monoclonal depletion antibody (clone: GK1.5) or matching isotype control (Rat IgG2B). IL-17A neutralization was performed using anti-IL-17A monoclonal antibody (clone: 17F3) or matching isotype control (Mouse IgG1). Antibodies were administered intraperitoneally, 500μg per day every 3 days for a total of 3 doses. Efficacy of CD4+ depletion was determined in colonic lamina propria and spleen by flow cytometry. For intestinal lamina propria lymphocytes isolation, tissue pieces were washed with cold PBS and incubated in RPMI with 1 mg/ml Collagenase/Dispase for 30 min at 37°C with shaking at 200 rpm. Splenocytes were disrupted into single cell suspension by passing the organ through 70 μm filter and RBCs were lysed in ACK lysis buffer (Invitrogen) for 3 min. Cells were stained using the following monoclonal fluorescence-conjugated antibodies: BUV395 anti-CD45.2 (Clone: 104, BD Biosciences), APC-eFluor 780 anti-CD4 (Clone: RM4–5, eBioscience), and APC anti-CD8a (Clone: 53–6.7, eBioscience). All antibodies were diluted in FACS buffer (2% FBS, 0.01 Sodium Azide, PBS). Dead cells were gated out by using the Fixable Violet Dead Cell Stain Kit (Invitrogen). Samples were acquired on the BD LSRFortessa (BD Biosciences) and analyzed with FlowJo Software (Treestar).
+ Open protocol
+ Expand
9

CD4+ Cell Depletion and Lamina Propria Isolation

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD4 + cells were depleted using anti-CD4 monoclonal depletion antibody (clone: GK1.5) or matching isotype control (Rat IgG2B) administered intraperitoneally, 500µg per day every 3 days for a total of 3 doses. Efficacy of CD4 + depletion was determined in colonic lamina propria and spleen by flow cytometry. For intestinal lamina propria lymphocytes isolation, tissue pieces were washed with cold PBS and incubated in RPMI with 1 mg/ml Collagenase/Dispase for 30 min at 37˙C with shaking at 200 rpm. Splenocytes were disrupted into single cell suspension by passing the organ through 70 µm filter and RBCs were lysed in ACK lysis buffer (Invitrogen) for 3 min. Cells were stained using the following monoclonal fluorescence-conjugated antibodies: BUV395 anti-CD45.2 (Clone: 104, BD Biosciences), APC-eFluor 780 anti-CD4 (Clone: RM4-5, eBioscience), and APC anti-CD8a (Clone: 53-6.7, eBioscience). All antibodies were diluted in FACS buffer (2% FBS, 0.01 Sodium Azide, PBS). Dead cells were gated out by using the Fixable Violet Dead Cell Stain Kit (Invitrogen). Samples were acquired on the BD LSRFortessa (BD Biosciences) and analyzed with FlowJo Software (Treestar).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!